Profile | GDS4284 / 239815_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4618.96 | 93 |
GSM687648 | Patient 402 control | 4454.93 | 92 |
GSM687653 | Patient 403 control | 5672.8 | 94 |
GSM687658 | Patient 404 control | 5547.7 | 94 |
GSM687663 | Patient 411 control | 4848.42 | 93 |
GSM687668 | Patient 422 control | 5476.49 | 94 |
GSM687673 | Patient 424 control | 4675.71 | 93 |
GSM687678 | Patient 425 control | 5884.53 | 95 |
GSM687683 | Patient 427 control | 4754.25 | 93 |
GSM687688 | Patient 428 control | 5414.83 | 94 |
GSM687695 | Patient 441 control | 2062.66 | 86 |
GSM687699 | Patient 443 control | 4783.06 | 93 |
GSM687704 | Patient 444 control | 7708.63 | 96 |
GSM687707 | Patient 448 control | 6330.56 | 95 |
GSM687712 | Patient 449 control | 3250.24 | 90 |
GSM687719 | Patient 450 control | 3286.77 | 90 |
GSM687724 | Patient 451 control | 6517.38 | 95 |
GSM687728 | Patient 452 control | 5036.31 | 93 |
GSM687646 | Patient 401 treated 24h | 5844.23 | 94 |
GSM687649 | Patient 402 treated 24h | 4776.79 | 93 |
GSM687665 | Patient 411 treated 24h | 5368.26 | 94 |
GSM687651 | Patient 402 treated 4 weeks | 4737.29 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 5452.5 | 94 |
GSM687670 | Patient 422 treated 24h | 5071.46 | 93 |
GSM687671 | Patient 422 treated 4 weeks | 4760.86 | 93 |
GSM687654 | Patient 403 treated 24h | 5813.76 | 94 |
GSM687675 | Patient 424 treated 24h | 3997.04 | 92 |
GSM687685 | Patient 427 treated 24h | 3976.48 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 5200.88 | 94 |
GSM687677 | Patient 424 treated 4 weeks | 5783.04 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 5195.6 | 94 |
GSM687692 | Patient 428 treated 4h | 6944.65 | 95 |
GSM687716 | Patient 449 treated 4h | 4305.75 | 92 |
GSM687722 | Patient 450 treated 4h | 4421.73 | 93 |
GSM687680 | Patient 425 treated 24h | 6209.35 | 95 |
GSM687690 | Patient 428 treated 24h | 5076.84 | 93 |
GSM687700 | Patient 443 treated 24h | 3834.68 | 92 |
GSM687705 | Patient 444 treated 24h | 7111.15 | 95 |
GSM687714 | Patient 449 treated 24h | 3910.44 | 91 |
GSM687721 | Patient 450 treated 24h | 3298.79 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 7453.33 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 5470.9 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 3775.97 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 4614.76 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 5150.76 | 94 |
GSM687661 | Patient 404 treated 4h | 5169.82 | 94 |
GSM687710 | Patient 448 treated 4h | 4703.49 | 93 |
GSM687726 | Patient 451 treated 4h | 6724.16 | 95 |
GSM687730 | Patient 452 treated 4h | 4586.15 | 94 |
GSM687660 | Patient 404 treated 24h | 2691.96 | 88 |
GSM687697 | Patient 441 treated 24h | 2944.02 | 89 |
GSM687709 | Patient 448 treated 24h | 5858.45 | 94 |
GSM687725 | Patient 451 treated 24h | 6333.31 | 95 |
GSM687729 | Patient 452 treated 24h | 2445.35 | 88 |
GSM687727 | Patient 451 treated 4 weeks | 9269.8 | 97 |
GSM687731 | Patient 452 treated 4 weeks | 4439.44 | 92 |